Oral Session 1-11D AML: Pathophysiology (2)

[OS1-11D-5] Identification of GPAT1 as a novel therapeutic target for AML by inhibiting AML-specific metabolism

Hidetoshi Irifune^1,2, Yu Kochi^1,2, Masayasu Hayashi^1,2, Yoshikane Kikushige¹, Toshihiro Miyamoto^1,3, Koichi Akashi^1,2,3 (1.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2.Center for Cellular and Molecular Medicine, Kyushu University, Fukuoka, Japan, 3.Hematology/Oncology/Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan)